
- RIUMA Principal
- Listar por autor
Listar por autor "Macías, Juan"
Mostrando ítems 1-3 de 3
-
Incidence of and factors associated with SARS-CoV-2 infection among people living with HIV in Southern Spain after one year of pandemic
Fernández-Fuertes, Marta; Corma-Gómez, Anaïs; Torres, Eva; Rodriguez-Pineda, Elena; Fuentes-López, Ana; Rincon, Pilar; Fernández, Nieves; García, Federico; Bernal, Samuel; Real-Navarrete, Luis Miguel; Macías, Juan; Pineda, Juan A.[et al.] (Wiley, 2021-08-17)
Whether people living with HIV (PLWH) are at greater risk of acquiring SARS-CoV-2 infection is currently unknown. Prospective serologic studies may allow seroincidence analyses, where all infections are accurately identified. ... -
Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain.
González-Serna, A.; Macías, Juan; Palacios-Muñoz, María Rosario; Gómez Ayerbe, Cristina; Téllez-Rico, Francisco Javier
; Rivero-Juárez, Antonio; Fernández, M.; Santos-González, Jesús Leandro
; Real-Navarrete, Luis Miguel
; González-Doménech, Carmen María
; Gómez-Mateos, J.; Pineda, Juan Antonio; HEPAVIR study group[et al.] (2020-12-26)
Objectives: Spain is close to HCV microelimination, so rates of recently acquired HCV infection (RAHC) should decrease. Nowadays, men who have sex with men (MSM) carry the highest risk of HCV acquisition. Our aim was to ... -
The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study).
Martín-Sierra, Carmen; Bravo-Romero, María José; Saez, Maria Eugenia; De Rojas, Itziar; Santos, Marta; Martín-Carmona, Jesica; Corma-Gómez, Anaïs; González-Serna, Alejandro; Royo-Sánchez-Palencia, José Luis
; Pineda, Juan A.; Rivero, Antonio; Rivero-Juárez, Antonio; Macías, Juan; Real-Navarrete, Luis Miguel
[et al.] (Elsevier, 2024)
Background & aims It has been reported that specific killer-cell immunoglobulin-like receptors (KIRs) and HLA genotype combinations, such as KIR2DS4/HLA-C1 with presence of KIRDL2 or KIRDL3, homozygous KIRDL3/HLA-C1 and ...